Whole-Exome Sequencing Identifies a Novel CPT2 Mutation in a Pedigree With Gout
- 1Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- 2Zhejiang Center for Clinical Laboratory, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China
- 3Department of Internal Medicine, Yueqing People’s Hospital, Yueqing, China
- 4Wenzhou Medical University, Wenzhou, China
- 5Department of Rheumatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- 6Department of Injury Orthopaedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
A Corrigendum on
Whole-exome sequencing identifies a novel CPT2 mutation in a pedigree with gout
by Guo, Y., Jin, J., Zhou, Z., Chen, Y., Sun, L., Zhang, C., and Xia, X. (2022). Front. Cell Dev. Biol. 10:802635. doi: 10.3389/fcell. 2022.802635
In the published article, there was an error in affiliations 1 and 6. Instead of “The First Affiliated Hospital of Wenzhou University”, it should be “The First Affiliated Hospital of Wenzhou Medical University”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: whole-exome sequencing, novel mutation, gout, CPT2 gene, pedigree
Citation: Guo Y, Jin J, Zhou Z, Chen Y, Sun L, Zhang C and Xia X (2022) Corrigendum: Whole-exome sequencing identifies a novel CPT2 mutation in a pedigree with gout. Front. Cell Dev. Biol. 10:988348. doi: 10.3389/fcell.2022.988348
Received: 08 July 2022; Accepted: 08 July 2022;
Published: 04 August 2022.
Approved by:
Frontiers in Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Guo, Jin, Zhou, Chen, Sun, Zhang and Xia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoru Xia, xxr7799@163.com
†These authors have contributed equally to this work